HitGen Inc Sustainability Reports
HitGen Inc. is a biopharmaceutical company focused on early-stage drug discovery. It operates technology platforms centered around DNA-encoded chemical libraries, fragment-based drug discovery, and structure-based drug design.
Sector: Professional & technical services
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00L1B3LG0
1 reports from 2025 to 2025
